{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:51:12Z","timestamp":1792461072796,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>IL-22 is a potent pro-inflammatory cytokine upregulated in psoriasis and in other inflammatory diseases. The function of IL-22 is regulated by the soluble scavenging receptor, IL-22 binding protein (IL-22BP or IL-22RA2). However, the role and regulation of IL-22BP itself in the pathogenesis of inflammatory disease remain unclear. We used the TLR7 agonist Imiquimod (IMQ) to induce a psoriasis-like skin disease in mice and found a strong downregulation of IL-22BP in the affected skin as well as in the lymph nodes of animals treated with IMQ. We also analysed psoriatic skin of patients and compared this to skin of healthy donors. Interestingly, IL-22BP expression was similarly downregulated in skin biopsies of psoriasis patients compared to the skin of healthy donors. Since IL-22BP is expressed foremost in dendritic cells, we characterized its expression in monocyte-derived dendritic cells (MoDC) during maturation. In this way, we found Prostaglandin E2 (PGE<jats:sub>2<\/jats:sub>) to be a potent suppressor of IL-22BP expression <jats:italic>in vitro<\/jats:italic>. We conclude that regulation of IL-22BP by inflammatory mediators is an important step for the progression of inflammation in the skin and possibly also in other autoimmune diseases.<\/jats:p>","DOI":"10.1038\/s41598-018-23510-3","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T01:44:07Z","timestamp":1522287847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Regulation of IL-22BP in psoriasis"],"prefix":"10.1038","volume":"8","author":[{"given":"Stefanos","family":"Voglis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Kloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morad","family":"Zayoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Pelczar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios D.","family":"Giannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Luessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Sch\u00e4kel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7550-0681","authenticated-orcid":false,"given":"Florian C.","family":"Kurschus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"key":"23510_CR1","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.4049\/jimmunol.164.4.1814","volume":"164","author":"L Dumoutier","year":"2000","unstructured":"Dumoutier, L., Louahed, J. & Renauld, J. C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. Journal of immunology 164, 1814\u20131819 (2000).","journal-title":"Journal of immunology"},{"key":"23510_CR2","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1016\/j.febslet.2008.07.046","volume":"582","author":"L Bleicher","year":"2008","unstructured":"Bleicher, L. et al. Crystal structure of the IL-22\/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett 582, 2985\u20132992, https:\/\/doi.org\/10.1016\/j.febslet.2008.07.046 (2008).","journal-title":"FEBS Lett"},{"key":"23510_CR3","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.4049\/jimmunol.1100482","volume":"187","author":"Y Ke","year":"2011","unstructured":"Ke, Y., Sun, D., Jiang, G., Kaplan, H. J. & Shao, H. IL-22-induced regulatory CD11b\u2009+\u2009APCs suppress experimental autoimmune uveitis. Journal of immunology 187, 2130\u20132139, https:\/\/doi.org\/10.4049\/jimmunol.1100482 (2011).","journal-title":"Journal of immunology"},{"key":"23510_CR4","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.4049\/jimmunol.0902587","volume":"183","author":"R Dhiman","year":"2009","unstructured":"Dhiman, R. et al. IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. Journal of immunology 183, 6639\u20136645, https:\/\/doi.org\/10.4049\/jimmunol.0902587 (2009).","journal-title":"Journal of immunology"},{"key":"23510_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","volume":"32","author":"K Wolk","year":"2010","unstructured":"Wolk, K., Witte, E., Witte, K., Warszawska, K. & Sabat, R. Biology of interleukin-22. Semin Immunopathol 32, 17\u201331, https:\/\/doi.org\/10.1007\/s00281-009-0188-x (2010).","journal-title":"Semin Immunopathol"},{"key":"23510_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cyto.2014.09.007","volume":"74","author":"E Nikoopour","year":"2015","unstructured":"Nikoopour, E., Bellemore, S. M. & Singh, B. IL-22, cell regeneration and autoimmunity. Cytokine 74, 35\u201342, https:\/\/doi.org\/10.1016\/j.cyto.2014.09.007 (2015).","journal-title":"Cytokine"},{"key":"23510_CR7","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.4049\/jimmunol.166.12.7090","volume":"166","author":"L Dumoutier","year":"2001","unstructured":"Dumoutier, L., Lejeune, D., Colau, D. & Renauld, J. C. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor\/IL-22. J Immunol 166, 7090\u20137095 (2001).","journal-title":"J Immunol"},{"key":"23510_CR8","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1073\/pnas.171303198","volume":"98","author":"W Xu","year":"2001","unstructured":"Xu, W. et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci USA 98, 9511\u20139516, https:\/\/doi.org\/10.1073\/pnas.171303198 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"23510_CR9","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.4049\/jimmunol.166.12.7096","volume":"166","author":"SV Kotenko","year":"2001","unstructured":"Kotenko, S. V. et al. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol 166, 7096\u20137103 (2001).","journal-title":"J Immunol"},{"key":"23510_CR10","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.4049\/jimmunol.178.9.5973","volume":"178","author":"K Wolk","year":"2007","unstructured":"Wolk, K. et al. IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn\u2019s disease. Journal of immunology 178, 5973\u20135981 (2007).","journal-title":"Journal of immunology"},{"key":"23510_CR11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.str.2008.06.005","volume":"16","author":"BC Jones","year":"2008","unstructured":"Jones, B. C., Logsdon, N. J. & Walter, M. R. Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure 16, 1333\u20131344, https:\/\/doi.org\/10.1016\/j.str.2008.06.005 (2008).","journal-title":"Structure"},{"key":"23510_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/sj.gene.6364104","volume":"5","author":"B Weiss","year":"2004","unstructured":"Weiss, B. et al. Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart. Genes Immun 5, 330\u2013336, https:\/\/doi.org\/10.1038\/sj.gene.6364104 (2004).","journal-title":"Genes Immun"},{"key":"23510_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/mi.2013.28","volume":"7","author":"JC Martin","year":"2014","unstructured":"Martin, J. C. et al. Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Mucosal Immunol 7, 101\u2013113, https:\/\/doi.org\/10.1038\/mi.2013.28 (2014).","journal-title":"Mucosal Immunol"},{"key":"23510_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nature11535","volume":"491","author":"S Huber","year":"2012","unstructured":"Huber, S. et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491, 259\u2013263, https:\/\/doi.org\/10.1038\/nature11535 (2012).","journal-title":"Nature"},{"key":"23510_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.aah5903","volume":"354","author":"P Pelczar","year":"2016","unstructured":"Pelczar, P. et al. A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease. Science 354, 358\u2013362, https:\/\/doi.org\/10.1126\/science.aah5903 (2016).","journal-title":"Science"},{"key":"23510_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/mi.2015.83","volume":"9","author":"JC Martin","year":"2016","unstructured":"Martin, J. C. et al. IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis. Mucosal Immunol 9, 539\u2013549, https:\/\/doi.org\/10.1038\/mi.2015.83 (2016).","journal-title":"Mucosal Immunol"},{"key":"23510_CR17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1172\/JCI33194","volume":"118","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto, K. et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118, 534\u2013544, https:\/\/doi.org\/10.1172\/JCI33194 (2008).","journal-title":"J Clin Invest"},{"key":"23510_CR18","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes, M. A., Bowcock, A. M. & Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866\u2013873, https:\/\/doi.org\/10.1038\/nature05663 (2007).","journal-title":"Nature"},{"key":"23510_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/bjd.14446","volume":"174","author":"F Kurschus","year":"2016","unstructured":"Kurschus, F. Of men and mice: analysing the action of an established drug using tumour necrosis factor-alpha-deficient mice in the imiquimod psoriasis model. Br J Dermatol 174, 955\u2013956, https:\/\/doi.org\/10.1111\/bjd.14446 (2016).","journal-title":"Br J Dermatol"},{"key":"23510_CR20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1001\/archderm.140.12.1490","volume":"140","author":"M Gilliet","year":"2004","unstructured":"Gilliet, M. et al. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 140, 1490\u20131495, https:\/\/doi.org\/10.1001\/archderm.140.12.1490 (2004).","journal-title":"Arch Dermatol"},{"key":"23510_CR21","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182, 5836\u20135845, https:\/\/doi.org\/10.4049\/jimmunol.0802999 (2009).","journal-title":"J Immunol"},{"key":"23510_CR22","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A Di Cesare","year":"2009","unstructured":"Di Cesare, A., Di Meglio, P. & Nestle, F. O. The IL-23\/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129, 1339\u20131350, https:\/\/doi.org\/10.1038\/jid.2009.59 (2009).","journal-title":"J Invest Dermatol"},{"key":"23510_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/jid.2013.404","volume":"134","author":"AL Croxford","year":"2014","unstructured":"Croxford, A. L. et al. IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions. J Invest Dermatol 134, 728\u2013735, https:\/\/doi.org\/10.1038\/jid.2013.404 (2014).","journal-title":"J Invest Dermatol"},{"key":"23510_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648\u2013651, https:\/\/doi.org\/10.1038\/nature05505 (2007).","journal-title":"Nature"},{"key":"23510_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1172\/JCI33263","volume":"118","author":"HL Ma","year":"2008","unstructured":"Ma, H. L. et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. The Journal of clinical investigation 118, 597\u2013607, https:\/\/doi.org\/10.1172\/JCI33263 (2008).","journal-title":"The Journal of clinical investigation"},{"key":"23510_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4049\/jimmunol.1102224","volume":"188","author":"AB Van Belle","year":"2012","unstructured":"Van Belle, A. B. et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol 188, 462\u2013469, https:\/\/doi.org\/10.4049\/jimmunol.1102224 (2012).","journal-title":"J Immunol"},{"key":"23510_CR27","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/eji.200535503","volume":"36","author":"K Wolk","year":"2006","unstructured":"Wolk, K. et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. European journal of immunology 36, 1309\u20131323, https:\/\/doi.org\/10.1002\/eji.200535503 (2006).","journal-title":"European journal of immunology"},{"key":"23510_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2249.2007.03511.x","volume":"150","author":"K Boniface","year":"2007","unstructured":"Boniface, K. et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 150, 407\u2013415, https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03511.x (2007).","journal-title":"Clin Exp Immunol"},{"key":"23510_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/jid.2012.318","volume":"133","author":"K El Malki","year":"2013","unstructured":"El Malki, K. et al. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. J Invest Dermatol 133, 441\u2013451, https:\/\/doi.org\/10.1038\/jid.2012.318 (2013).","journal-title":"J Invest Dermatol"},{"key":"23510_CR30","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1002\/eji.1830271209","volume":"27","author":"H Jonuleit","year":"1997","unstructured":"Jonuleit, H. et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. European journal of immunology 27, 3135\u20133142, https:\/\/doi.org\/10.1002\/eji.1830271209 (1997).","journal-title":"European journal of immunology"},{"key":"23510_CR31","doi-asserted-by":"publisher","first-page":"Suppl, S29","DOI":"10.1194\/jlr.R800042-JLR200","volume":"50","author":"CA Rouzer","year":"2009","unstructured":"Rouzer, C. A. & Marnett, L. J. Cyclooxygenases: structural and functional insights. Journal of lipid research 50, Suppl, S29\u201334, https:\/\/doi.org\/10.1194\/jlr.R800042-JLR200 (2009).","journal-title":"Journal of lipid research"},{"key":"23510_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons, D. L., Botting, R. M. & Hla, T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacological reviews 56, 387\u2013437, https:\/\/doi.org\/10.1124\/pr.56.3.3 (2004).","journal-title":"Pharmacological reviews"},{"key":"23510_CR33","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","volume":"26","author":"TJ Gan","year":"2010","unstructured":"Gan, T. J. Diclofenac: an update on its mechanism of action and safety profile. Current medical research and opinion 26, 1715\u20131731, https:\/\/doi.org\/10.1185\/03007995.2010.486301 (2010).","journal-title":"Current medical research and opinion"},{"key":"23510_CR34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700021","author":"JC Martin","year":"2017","unstructured":"Martin, J. C. et al. Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation. J Immunol, https:\/\/doi.org\/10.4049\/jimmunol.1700021 (2017).","journal-title":"J Immunol"},{"key":"23510_CR35","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11481-013-9466-4","volume":"8","author":"M Zayoud","year":"2013","unstructured":"Zayoud, M. et al. Subclinical CNS inflammation as response to a myelin antigen in humanized mice. J Neuroimmune Pharmacol 8, 1037\u20131047, https:\/\/doi.org\/10.1007\/s11481-013-9466-4 (2013).","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23510-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23510-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23510-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:51:31Z","timestamp":1671594691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23510-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["23510"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-23510-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,23]]},"assertion":[{"value":"4 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A. is employee of Phenex Pharmaceuticals AG, Heidelberg, Germany and hold stock and\/or stock options of his company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5085"}}